Amphetamine Stimulant Prodrug denied for failing step therapy by Humana?

Humana's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Applies Step Therapy to This Amphetamine Prodrug

Humana's formulary management program requires that patients try one or more "step" medications — typically lower-tier or lower-cost stimulants — before authorizing this amphetamine-based prodrug. Step therapy protocols are common across stimulant medications because multiple FDA-approved options exist within the class. The denial does not reflect a judgment that the prodrug is clinically inappropriate; it reflects a formulary-sequencing requirement.

## Why This Denial Is Appealable

Step therapy overrides are explicitly permitted under most state laws and under ERISA guidance when a required step drug is contraindicated, has already been tried and failed, or would cause clinically significant delay in effective treatment. If your patient has already tried the required prior medications — or has a documented clinical reason to skip them — a step exception appeal has strong grounds.

## Federal Appeal Framework

• Internal appeal: The denial notice must state the specific step-therapy criteria. You have the right to appeal internally, typically within 180 days (ERISA) or the period stated on the denial.
• External review (ACA §2719 / ERISA §503): Following a final internal denial, you may request independent external review. The standard window is approximately four months from the final internal denial date. Expedited review (typically 72 hours) is available when delay would seriously jeopardize health.
• Step therapy override laws: Many states have enacted step therapy override statutes requiring insurers to grant exceptions when clinical criteria are met. Check whether your state's law applies to your plan type.

## Concrete Appeal Steps and Timeline

1. Obtain Humana's step-therapy criteria for this drug in writing. 2. Document each required prior step — what was tried, for how long, at what dose range per the prescribing label, and what the outcome was. 3. Submit the internal step-exception request with the prescriber's letter and supporting chart records. 4. Escalate to external review if the internal appeal is denied, within the four-month window.

## Documentation to Gather

• Prior medication history: Names of required step drugs, dates of trials, documented reasons for discontinuation (inadequate response, adverse effects, contraindication).
• Diagnosis and severity documentation: Chart notes establishing the diagnosed condition, its functional impact, and clinical urgency.
• Prescriber medical-necessity letter: Should explain why the prodrug formulation is specifically needed (e.g., smoother duration of effect, reduced abuse potential per the label, tolerability) and why required step agents are not appropriate.
• Specialist assessments: If applicable, supporting notes from psychiatry, neurology, or the relevant specialty.

## Criteria-Mapping Structure

Build a direct response table:

| Humana Step-Therapy Requirement | Patient Evidence | |---|---| | List each step drug required by Humana's policy | Confirm trial date, duration, and outcome — or document clinical reason for exception | | Any additional clinical criteria for override | Cite specific chart note and prescriber statement addressing each |

Explicit, date-anchored documentation of prior failures is the single most persuasive element of a step-therapy appeal.